Search

Search results

3013 results found

Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?

De Mello, Munique Kurtz, Natália Sousa Freitas Queiroz, and Konstantinos Papamichael. 2024. “Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (1): 200-201.

Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial.

Cheifetz, Adam S, Niels Vande Casteele, Zhongya Wang, Marla C Dubinsky, and Konstantinos Papamichael. 2023. “Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn’s Disease: A Post Hoc Analysis of the REACH Trial.”. The American Journal of Gastroenterology 118 (3): 485-90.

Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.

Shah, Ishani, Andy Silva-Santisteban, Katharine A Germansky, Vaibhav Wadhwa, Nadine Tung, Dora C Huang, Cinthana Kandasamy, Jack Mlabasati, Mohammad Bilal, and Mandeep S Sawhney. 2023. “Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.”. Journal of Clinical Gastroenterology 57 (3): 317-23.